These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38092570)

  • 1. Salivary gland cancer: Recommendations by formal consensus, for the French Network of Rare Head and Neck Tumors (REFCOR).
    Vergez S; Chabrillac E; Fakhry N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2024 Jan; 141(1):3-4. PubMed ID: 38092570
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytopathological analysis of salivary gland cancer: REFCOR recommendations by the formal consensus method.
    Courtade-Saïdi M; Uro-Coste E; Vergez S; Verillaud B; Pham Dang N; Chabrillac E; Fakhry N; Bigorgne C; Costes-Martineau V
    Eur Ann Otorhinolaryngol Head Neck Dis; 2024 Mar; 141(2):87-91. PubMed ID: 38052703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node surgery for salivary gland cancer: REFCOR recommendations by the formal consensus method.
    Baujat B; Vergez S; Jegoux F; Barry B; Verillaud B; Pham Dang N; Fakhry N; Chabrillac E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2024 Aug; 141(4):215-220. PubMed ID: 38036313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery of major salivary gland cancers: REFCOR recommendations by the formal consensus method.
    Barry B; Verillaud B; Jegoux F; Pham Dang N; Baujat B; Chabrillac E; Vergez S; Fakhry N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2024 May; 141(3):153-160. PubMed ID: 38040591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic imaging of salivary gland cancers: REFCOR recommendations by the formal consensus method.
    Varoquaux A; Fakhry N; Baujat B; Verillaud B; Jegoux F; Barry B; Chabrillac E; Vergez S; Terroir-Cassou-Mounat M
    Eur Ann Otorhinolaryngol Head Neck Dis; 2024 Jan; 141(1):27-31. PubMed ID: 38036312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy for salivary gland cancer: REFCOR recommendations by the formal consensus method.
    Thariat J; Ferrand FR; Fakhry N; Even C; Vergez S; Chabrillac E; Sarradin V; Digue L; Troussier I; Bensadoun RJ
    Eur Ann Otorhinolaryngol Head Neck Dis; 2024 Aug; 141(4):221-226. PubMed ID: 38030445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rare tumors of the head and neck; on behalf of the REFCOR, the French Network of rare head and neck tumors].
    Baujat B; Thariat J; Baglin AC; Costes V; Testelin S; Reyt E; Janot F;
    Bull Cancer; 2014 May; 101(5):411-23. PubMed ID: 24886891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve years after: The french national network on rare head and neck tumours (REFCOR).
    Gasne C; Atallah S; Dauzier E; Thariat J; Fakhry N; Verillaud B; Classe M; Vergez S; Moya-Plana A; Costes-Martineau V; Righini C; de Gabory L; Digue L; Dupin C; Ferrand FR; Even C; Baujat B;
    Oral Oncol; 2024 Apr; 151():106762. PubMed ID: 38513311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of cN0 low-grade mucoepidermoid carcinomas of salivary glands: Prospective multicentre study of 152 cases of the French Network of Rare Head and Neck Tumors (REFCOR).
    Saloner Dahan L; Giorgi R; Garrel R; Le Taillandier de Gabory L; Costes-Martineau V; Herman P; Poissonnet G; Mauvais O; Malard O; Vergez S; Uro-Coste E; Barry B; Bach C; Chevalier D; Mouawad F; Merol JC; Bastit V; Thariat J; Gilain L; Dufour X; Righini CA; Dessi P; Michel J; Radulesco T; Even C; Baujat B; Fakhry N
    Clin Otolaryngol; 2020 Nov; 45(6):926-931. PubMed ID: 32569444
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rare cancers of the head and neck on behalf of the REFCOR, part 1].
    Chabrillac E; Even C; Costes-Martineau V; Fakhry N; Digue L; Moya-Plana A; Baujat B; Righini CA; De Gabory L; Verillaud B; Vergez S; Thariat J;
    Bull Cancer; 2023 Jun; 110(6):692-699. PubMed ID: 37169603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network).
    Cerda T; Sun XS; Vignot S; Marcy PY; Baujat B; Baglin AC; Ali AM; Testelin S; Reyt E; Janot F; Thariat J
    Crit Rev Oncol Hematol; 2014 Aug; 91(2):142-58. PubMed ID: 24636481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases.
    Dahan LS; Giorgi R; Vergez S; Le Taillandier de Gabory L; Costes-Martineau V; Herman P; Poissonnet G; Mauvais O; Malard O; Garrel R; Uro-Coste E; Barry B; Bach C; Chevalier D; Mouawad F; Merol JC; Bastit V; Thariat J; Gilain L; Dufour X; Righini CA; Moya-Plana A; Even C; Radulesco T; Michel J; Baujat B; Fakhry N;
    Eur J Surg Oncol; 2021 Jun; 47(6):1376-1383. PubMed ID: 33248902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery of sublingual and minor salivary gland cancer: REFCOR recommendations by the formal consensus method.
    Pham Dang N; Jegoux F; Barry B; Verillaud B; Baujat B; Fakhry N; Chabrillac E; Vergez S
    Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Dec; ():. PubMed ID: 38052702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-treatment monitoring of salivary gland cancer: REFCOR recommendations by the formal consensus method.
    Chabrillac E; Vergez S; Barry B; Jegoux F; Verillaud B; Pham Dang N; Baujat B; Fakhry N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Nov; ():. PubMed ID: 38030444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rare cancers of the head and neck on behalf of the REFCOR, part 2].
    Chabrillac E; Even C; Costes-Martineau V; Fakhry N; Digue L; Moya-Plana A; Baujat B; Righini CA; De Gabory L; Verillaud B; Vergez S; Thariat J;
    Bull Cancer; 2023 Jun; 110(6):700-706. PubMed ID: 37169602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapies for salivary gland carcinoma (excluding adenoid cystic carcinoma): REFCOR recommendations by the formal consensus method.
    Sarradin V; Digue L; Vergez S; Thariat J; Fakhry N; Chabrillac E; Bensadoun RJ; Ferrand FR; Even C
    Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Nov; ():. PubMed ID: 38040592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations.
    De Felice F; de Vincentiis M; Valentini V; Musio D; Mezi S; Lo Mele L; Della Monaca M; D'Aguanno V; Terenzi V; Di Brino M; Brauner E; Bulzonetti N; Tenore G; Pomati G; Cassoni A; Tombolini M; Battisti A; Greco A; Pompa G; Minni A; Romeo U; Cortesi E; Polimeni A; Tombolini V
    Crit Rev Oncol Hematol; 2017 Dec; 120():93-97. PubMed ID: 29198342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors.
    Atallah S; Casiraghi O; Fakhry N; Wassef M; Uro-Coste E; Espitalier F; Sudaka A; Kaminsky MC; Dakpe S; Digue L; Bouchain O; Morinière S; Hourseau M; Bertolus C; Jegoux F; Thariat J; Calugaru V; Schultz P; Philouze P; Mauvais O; Righini CA; Badoual C; Saroul N; Goujon JM; Marie JP; Taouachi R; Brenet E; Aupérin A; Baujat B
    Eur J Cancer; 2020 May; 130():241-249. PubMed ID: 32171628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic therapies for salivary gland cancer: Adenoid cystic carcinoma. REFCOR recommendations by the formal consensus method.
    Ferrand FR; Even C; Chabrillac E; Thariat J; Fakhry N; Vergez S; Bensadoun RJ; Sarradin V; Digue L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Dec; ():. PubMed ID: 38061943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor Salivary Gland Cancer of the Head and Neck: A Review of Epidemiologic Aspects, Prognostic Factors, and Outcomes.
    Moretz-Sohn PF; Dias FL; de Carvalho Marques CM
    Curr Oncol Rep; 2023 Mar; 25(3):173-179. PubMed ID: 36705878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.